Flat $5 shipping — FREE on orders $49+!
No salt. No electrolytes. They drink because they love the flavor.
See what horse owners are saying →
Build a custom bundle & save
Shop
All Products Travel Size 2lb Pouches Build a Bundle & Save
Professionals
Equine Practitioners 501(c)(3) Horse Rescues
Learn
Blog FAQ Our Story Horse Owner Reviews
Start Here
Account Cart

Category: The Science

Peer-reviewed research on Improve Equine ingredients

  • DHA from Algae: Omega-3 Fatty Acids in Inflammation and Allergic Response

    Docosahexaenoic acid (DHA) is a long-chain omega-3 polyunsaturated fatty acid found in highest concentrations in marine algae — the original biosynthetic source from which all dietary DHA ultimately derives. DHA and its downstream metabolites play a central role in resolving inflammation, modulating mast cell activity, and supporting immune regulation in both horses and other mammals. The choice to source DHA from algae rather than fish oil is a formulation decision grounded in stability, species-appropriateness, and supply chain control.

    Key Research

    Protectin D1, an Omega-3-Derived Lipid Mediator, Resolves Mast Cell-Driven Allergic Inflammation via FcεRI Signaling

    Biomed Pharmacother. 2025 Jun:187:118060.
    DOI: 10.1016/j.biopha.2025.118060 | PMID: 40253829

    Protectin D1 (PD1) is a specialized pro-resolving mediator derived from DHA. This study demonstrates that PD1 directly counteracts mast cell-mediated allergic inflammation — the same pathway that Benchmark targets via quercetin and spirulina. Key findings:

    • Oral PD1 markedly suppressed passive cutaneous anaphylaxis (PCA) reactions including ear swelling, plasma extravasation, and mast cell degranulation
    • In active systemic anaphylaxis models, PD1 administration reduced IgE-mediated mast cell activation via the FcεRI signaling pathway — the primary trigger for histamine release in allergic responses
    • This is direct mechanistic evidence linking DHA (as the precursor to Protectin D1) to resolution of the same mast cell degranulation and histamine pathways that drive equine allergic conditions

    Omega-3 Fatty Acid Supplementation in Horses with Chronic Lower Airway Inflammatory Disease

    Nogradi N, Couetil LL, Messick J, Stochelski MA, Burgess JR. J Vet Intern Med. 2015 Jan;29(1):299–306.
    DOI: 10.1111/jvim.12488 | PMID: 25307169

    This randomized, controlled clinical trial examined omega-3 PUFA supplementation in horses diagnosed with recurrent airway obstruction (RAO) and inflammatory airway disease (IAD) — the equine equivalents of heaves and chronic lower airway inflammation. Key findings:

    • Omega-3 supplementation provided additional measurable benefit beyond a low-dust diet alone in managing clinical signs and airway inflammation
    • Supplemented horses showed improvements in lung function and inflammatory markers in bronchoalveolar lavage fluid
    • The study directly supports the use of omega-3 fatty acids as part of a multi-ingredient approach to equine respiratory and inflammatory conditions

    DHA Oxymetabolites Modulate Inflammatory Response in Equine Synoviocytes

    Leclère M, de la Rebière de Pouyade G, Couture F, Laverty S, Lavoie JP. Prostaglandins Other Lipid Mediat. 2019 Jun:142:1–8.
    DOI: 10.1016/j.prostaglandins.2019.02.007 | PMID: 30836143

    This study examined how DHA and its downstream oxymetabolites (docosanoids) affect inflammatory mediator gene expression in equine joint cells stimulated with pro-inflammatory cytokines. Key findings:

    • DHA-derived oxylipids modulated the expression of inflammatory mediator genes in equine synoviocytes — direct in vitro evidence of DHA’s anti-inflammatory activity in horse tissue
    • The mechanism involves downstream conversion of DHA into pro-resolving specialized lipid mediators (SPMs) that actively turn off inflammatory gene expression
    • This supports the use of DHA specifically (not just generic omega-3) in addressing joint and tissue inflammation in horses

    Why Algae-Derived DHA

    Fish don’t make DHA — they concentrate it from eating algae. By going directly to the algae source, Benchmark avoids the fishy palatability issues that can reduce equine supplement acceptance, eliminates the oxidative rancidity risk inherent to fish oil concentrates, and provides DHA in a form that is more stable and consistently dosed. The science on DHA’s mechanism is the same regardless of source; the sourcing decision is about delivery quality and horse compliance.

    Note: These studies provide evidence for DHA’s anti-inflammatory and mast cell-modulatory mechanisms, including equine-specific research. Always consult a veterinarian regarding your horse’s specific health needs.

    Frequently Asked Questions: DHA and Omega-3s for Horses

    What does DHA do for horses?

    Short answer: DHA is the omega-3 precursor to specialized pro-resolving mediators (SPMs) — including Protectin D1 and resolvins — that actively turn off mast cell degranulation, IgE signaling, and inflammatory gene expression, making it a resolution-phase anti-inflammatory with direct evidence in equine tissue. Unlike anti-inflammatory compounds that block inflammatory pathways, DHA-derived SPMs actively signal the resolution of inflammation and initiate tissue repair. This is a distinct and complementary mechanism from the mast cell stabilization provided by quercetin and spirulina. Research in equine synoviocytes (joint cells) has confirmed DHA’s anti-inflammatory mechanism directly in horse tissue, not just in model organisms.

    Is algae-derived DHA better than fish oil for horses?

    Short answer: Algae-derived DHA is the original biosynthetic source — fish concentrate DHA by eating algae. For horses, algae DHA avoids the palatability problems of fish oil, eliminates rancidity risk, and delivers the same active DHA molecule with better stability and acceptance. Fish oil’s fishy odor and taste are significant barriers to equine supplement acceptance. Many horses refuse or reduce intake of feeds containing fish oil, which defeats the purpose. Algae-sourced DHA is flavorless, more oxidatively stable than fish oil concentrates, and provides the identical DHA molecule. For horses, supplement compliance is not a secondary concern — it is the primary one. A supplement the horse won’t eat provides no benefit at all.

    Can DHA help horses with heaves or inflammatory airway disease?

    Short answer: Yes — a randomized controlled clinical trial in horses with RAO and IAD found that omega-3 supplementation provided measurable benefit in lung function and airway inflammatory markers beyond a low-dust diet alone. This is equine-specific clinical trial evidence, not just mechanistic inference. The horses in the Nogradi et al. study showed improvements in bronchoalveolar lavage inflammatory cell counts and lung function with omega-3 supplementation — directly supporting DHA’s use in horses with chronic lower airway inflammation. Combined with quercetin, isoquercetin, spirulina, and MSM, DHA addresses the resolution phase of the airway inflammatory cycle that the other compounds help prevent.

    Does DHA help horses with joint inflammation?

    Short answer: Yes — DHA-derived oxylipids directly modulate inflammatory mediator gene expression in equine synoviocytes (joint cells), with specific in vitro evidence that DHA’s downstream pro-resolving mediators reduce inflammatory gene expression in horse joint tissue. This is one of the most directly applicable pieces of equine research in the Benchmark ingredient library — it was conducted in actual equine joint cells, not a surrogate model. For horses with joint inflammation, arthritis, or post-exercise joint soreness, DHA’s pro-resolving mechanism complements the anti-inflammatory activity of MSM and the antioxidant protection of ascorbyl palmitate. Together these three ingredients address joint health from prevention through resolution.

    Is DHA safe for metabolic horses or horses with Cushing’s disease?

    Short answer: Yes — DHA from algae is a fat-soluble compound with no sugar, no electrolytes, and no glycemic impact, making it appropriate for metabolic horses who need anti-inflammatory support without metabolic risk. Horses with Cushing’s disease (PPID) and insulin resistance often have elevated systemic inflammation as part of their condition. DHA’s pro-resolving anti-inflammatory mechanism is particularly relevant for these horses, who need ongoing inflammatory management but cannot tolerate many standard supplement ingredients. Algae DHA is one of the safest anti-inflammatory tools available for the metabolic horse population. Always confirm with your veterinarian for horses under active medical management. For a complete picture of equine health, see the Complete Guide to Horse Hydration, the Benchmark product page, and the full Improve Equine Library.

  • Ascorbyl Palmitate: Why Fat-Soluble Vitamin C Lasts Longer

    Ascorbyl Palmitate: Why Fat-Soluble Vitamin C Lasts Longer

    Ascorbyl palmitate is the fat-soluble (lipophilic) ester form of Vitamin C. Unlike standard ascorbic acid — which is water-soluble and clears from the body relatively quickly — ascorbyl palmitate integrates into lipid membranes and fatty tissues, providing extended antioxidant protection at the cellular level. This distinction matters for immune function, tissue defense, and the specific demands of an equine supplement designed to support allergy and inflammation pathways.

    Key Research

    Ascorbyl Palmitate Ameliorates Inflammatory Diseases by Inhibition of NLRP3 Inflammasome

    Int Immunopharmacol. 2024 Apr 20:131:111915.
    DOI: 10.1016/j.intimp.2024.111915 | PMID: 38522141

    This research demonstrates that ascorbyl palmitate (AP), as a lipophilic derivative of ascorbic acid, is a potent inhibitor of the NLRP3 inflammasome — a key driver of inflammation in chronic immune-mediated conditions. Key findings:

    • Compared to standard ascorbic acid, ascorbyl palmitate inhibited NLRP3 inflammasome activation with increased potency and specificity
    • The mechanism involves direct scavenging of mitochondrial reactive oxygen species (mitoROS) — a lipid-membrane-accessible activity that water-soluble ascorbic acid cannot replicate
    • Ascorbyl palmitate reduced downstream IL-1β release and inflammatory tissue damage in multiple in vivo inflammatory disease models

    NLRP3 inflammasome activation is implicated in allergic airway disease, skin hypersensitivity, and joint inflammation — making this mechanism directly relevant to the conditions Benchmark is formulated to address.

    Ascorbate 6-Palmitate Protects Cell Membranes from Oxidative Damage

    Hwang J, Hodis HN, Sevanian A. Free Radic Biol Med. 1999 Jan;26(1-2):81–9.
    DOI: 10.1016/s0891-5849(98)00198-1 | PMID: 9890643

    This study investigated why the fat-soluble form of ascorbate behaves differently from water-soluble ascorbic acid. Key findings:

    • Ascorbate 6-palmitate binds dose-dependently to cell membranes and is retained during membrane wash steps — confirming genuine membrane integration that water-soluble Vitamin C cannot achieve
    • Cells treated with ascorbate 6-palmitate showed significantly greater protection against lipid peroxidation and oxidative membrane damage compared to controls
    • The fat-soluble form provides antioxidant protection specifically at the lipid bilayer — the site of membrane phospholipid oxidation in inflammatory conditions

    This is the physiological basis for why ascorbyl palmitate is a more appropriate form of Vitamin C for an equine supplement targeting skin, airway mucosa, and joint tissues — all of which are lipid-rich environments.

    The Benchmark Formulation Rationale

    Standard water-soluble Vitamin C is renally cleared rapidly. Ascorbyl palmitate stays in circulation longer because it integrates into lipid membranes. For a horse dealing with chronic allergy, airway inflammation, or dermal hypersensitivity, sustained antioxidant coverage — not a quick spike and rapid clearance — is the goal. The fat-soluble form delivers that.

    Note: These studies support the rationale for choosing ascorbyl palmitate over standard ascorbic acid in a supplement designed for lipid-tissue antioxidant and anti-inflammatory support. Always consult a veterinarian regarding your horse’s specific health needs.

    Frequently Asked Questions: Ascorbyl Palmitate for Horses

    What is ascorbyl palmitate and why is it used in horse supplements?

    Short answer: Ascorbyl palmitate is the fat-soluble form of Vitamin C — it integrates into cell membranes and provides sustained antioxidant protection in lipid-rich tissues like skin, airway mucosa, and joints, where standard water-soluble Vitamin C cannot reach effectively. Standard ascorbic acid dissolves in water and is rapidly cleared by the kidneys, providing only a brief antioxidant window. Ascorbyl palmitate binds to lipid bilayers and remains in tissues far longer, protecting cell membranes from the oxidative damage that drives chronic inflammation. For horses with ongoing inflammatory conditions, sustained cellular antioxidant coverage is the goal — not a rapid spike and clearance.

    Does Vitamin C help horses with allergies or skin conditions?

    Short answer: Yes — but the form matters. Ascorbyl palmitate specifically inhibits the NLRP3 inflammasome, a key driver of chronic inflammatory conditions including allergic airway disease, skin hypersensitivity, and joint inflammation, with greater potency than standard Vitamin C. The NLRP3 inflammasome is a cellular complex that triggers IL-1β release and amplifies inflammation in chronic immune-mediated conditions. Ascorbyl palmitate’s ability to access mitochondrial reactive oxygen species (mitoROS) at the lipid membrane level — a mechanism water-soluble ascorbic acid cannot replicate — makes it specifically effective at suppressing NLRP3-driven inflammation. For horses with sweet itch, heaves, or chronic skin conditions, this targeted mechanism is directly relevant.

    Is ascorbyl palmitate better than regular Vitamin C for horses?

    Short answer: For supporting skin, airway, and joint tissue specifically — yes. Ascorbyl palmitate reaches and stays in the lipid-rich tissues where most equine inflammatory conditions manifest, while standard ascorbic acid is rapidly excreted and never reaches those cellular compartments effectively. Horses can synthesize some Vitamin C endogenously, but horses under significant inflammatory or oxidative stress may benefit from supplemental lipid-tissue antioxidant support. The choice of form is the key variable: water-soluble ascorbic acid addresses water-phase oxidative stress, while ascorbyl palmitate addresses lipid-phase oxidative stress at the cell membrane — a different and complementary target.

    How does ascorbyl palmitate work alongside DHA in horse inflammation support?

    Short answer: Ascorbyl palmitate and DHA are both lipid-membrane-active compounds that protect and resolve inflammation at the cellular level — they work in complementary phases, with ascorbyl palmitate protecting membranes from oxidative damage and DHA actively resolving inflammatory signaling through specialized pro-resolving mediators. DHA from algae generates resolvins and protectins — compounds that actively switch off the inflammatory response and signal tissue repair. Ascorbyl palmitate protects the integrity of the cell membranes in which DHA is embedded. Together they address both prevention and resolution of lipid-membrane-based inflammation. See the DHA research article for details.

    Is ascorbyl palmitate safe for horses with Cushing’s or insulin resistance?

    Short answer: Yes — ascorbyl palmitate is not a sugar-containing compound and does not affect insulin or glucose metabolism, making it appropriate for metabolic horses who need anti-inflammatory support without metabolic risk. Horses with Cushing’s disease or insulin resistance often have elevated inflammatory markers and oxidative stress alongside their metabolic condition, making antioxidant support particularly relevant. Ascorbyl palmitate’s lipid-soluble form provides this support without any of the glycemic concerns associated with sugar-based supplements. As always, confirm with your veterinarian for horses under active medical management. For an overview of the full equine supplement philosophy, visit the Improve Equine Library and the Complete Guide to Horse Hydration.

  • Bromelain: How It Enhances Quercetin Absorption and Effectiveness

    Bromelain: How It Enhances Quercetin Absorption and Effectiveness

    Bromelain is a proteolytic enzyme complex extracted from pineapple (Ananas comosus) stem. Beyond its own significant anti-inflammatory properties, bromelain plays a critical synergistic role with quercetin — enhancing its bioavailability and potentiating its effects at the site of action. This combination has been validated in peer-reviewed research on the mechanisms of flavonoid absorption and immune modulation.

    Key Research

    Bromelain as a Natural Anti-Inflammatory Drug: A Systematic Review

    Nobre TA, de Sousa AA, Pereira IC, et al. Nat Prod Res. 2025 Mar;39(5):1258–1271.
    DOI: 10.1080/14786419.2024.2342553 | PMID: 38676413

    This systematic review evaluated bromelain’s anti-inflammatory activity across in vitro studies on multiple cell lines. Key findings relevant to allergy and inflammation:

    • Bromelain reduced IL-1β, IL-6, and TNF-α secretion in immune cells stimulated by pro-inflammatory cytokines — modulating the inflammatory cascade rather than suppressing it indiscriminately
    • The mechanisms include reduction in prostaglandin synthesis and activation of neutrophil-regulating pathways that parallel the mechanisms of quercetin’s mast cell stabilization
    • Bromelain’s effects were consistent across multiple immune cell types, supporting its role as a broadly acting natural anti-inflammatory agent

    The Mechanism: How Bromelain Enhances Flavonoid Absorption

    Bromelain enhances quercetin absorption through several complementary mechanisms:

    • Gut permeability modulation: Bromelain selectively modifies tight junctions in intestinal epithelium, facilitating paracellular and transcellular absorption of large molecules including flavonoids
    • Mucolytic action: By breaking down mucus in the GI tract, bromelain reduces the diffusion barrier between the gut lumen and absorptive epithelial cells
    • Reduced first-pass metabolism: Bromelain’s anti-protease activity may protect quercetin from premature enzymatic degradation before absorption
    • Synergistic anti-inflammatory effects: Bromelain itself inhibits prostaglandin synthesis, bradykinin, and NF-κB activation — complementing quercetin’s mast cell-stabilizing mechanisms

    Bromelain’s Independent Anti-Inflammatory Properties

    Rathnavelu V, Alitheen NB, Sohila S, Kanagesan S, Ramesh R. Biomedical Reports. 2016 Sep;5(3):283–288.
    DOI: 10.3892/br.2016.720 | PMID: 27602208 | Free PMC Article

    Beyond its role as an absorption enhancer, bromelain has been shown to independently reduce inflammatory cytokines, inhibit platelet aggregation, and modulate immune cell activity. This study covers bromelain’s potential clinical and therapeutic applications in inflammatory conditions, including its inhibition of NF-κB signaling, COX-2 expression, and pro-inflammatory eicosanoid pathways. This means the bromelain in Benchmark contributes directly to the formula’s anti-inflammatory activity in addition to improving the delivery of other ingredients.

    The Benchmark Formulation Rationale

    Benchmark includes bromelain specifically because quercetin’s effectiveness is limited by its absorption. By pairing isoquercetin (the most bioavailable quercetin form) with bromelain (an absorption enhancer with its own anti-inflammatory properties), Benchmark is designed to maximize the amount of active quercetin that reaches systemic tissues — including airway mucosa, skin, and joints — where mast cell stabilization matters most for your horse.

    Note: These studies provide evidence for bromelain’s anti-inflammatory mechanisms and its role in enhancing quercetin bioavailability. Always consult a veterinarian regarding your horse’s specific health needs.

    Frequently Asked Questions: Bromelain for Horses

    What does bromelain do for horses?

    Short answer: Bromelain serves two roles in equine supplementation — it is an independent anti-inflammatory agent that reduces IL-1β, IL-6, TNF-α, NF-κB, and COX-2 activity, and it simultaneously enhances the absorption of quercetin and other flavonoids by improving gut permeability and reducing the diffusion barrier in the GI tract. For horses on a quercetin-based allergy or inflammation support protocol, bromelain is not just an addition — it is a multiplier. By improving quercetin bioavailability while contributing its own anti-inflammatory activity, bromelain allows the full quercetin-family stack to perform significantly better than any single ingredient could achieve alone.

    Why is bromelain paired with quercetin in horse supplements?

    Short answer: Quercetin’s major limitation is poor oral bioavailability — bromelain addresses this directly by modifying intestinal tight junctions to improve absorption, breaking down mucus diffusion barriers, and protecting quercetin from premature enzymatic degradation before it can be absorbed. This synergistic combination is one of the most well-studied flavonoid absorption pairings in nutritional research. The practical result for horses is that a bromelain-plus-quercetin formulation delivers meaningfully more active quercetin to systemic tissues — the airways, skin, and joints — than quercetin supplemented alone. The effect is further amplified when isoquercetin is used instead of standard quercetin. See the isoquercetin bioavailability article for the full picture.

    Is bromelain safe for horses?

    Short answer: Yes — bromelain has an established safety profile in both human and animal research, with no significant adverse effects observed at therapeutic doses. It is a naturally occurring enzyme from pineapple stem and is widely used in human nutritional and pharmaceutical applications. For horses, the primary consideration is that bromelain is a proteolytic enzyme and should be introduced gradually for horses with known GI sensitivity. It is not appropriate during active gastric ulcer flares where intestinal permeability changes are contraindicated. Always consult your veterinarian before introducing any new supplement to a horse with a known GI condition.

    Does bromelain help with horse skin allergies and sweet itch?

    Short answer: Yes — bromelain’s independent anti-inflammatory activity (reducing prostaglandins, bradykinin, and NF-κB) combined with its enhancement of quercetin absorption makes it a meaningful contributor to equine skin allergy management, particularly in combination with quercetin and spirulina. Sweet itch and insect bite hypersensitivity involve both mast cell degranulation and downstream inflammatory cascade activity — two mechanisms that bromelain addresses directly and indirectly. For horses with significant skin hypersensitivity, the bromelain-quercetin-isoquercetin-spirulina combination represents the most comprehensive natural approach supported by the current research literature.

    What is the full anti-inflammatory stack for horses with allergies?

    Short answer: The most research-supported natural equine allergy and inflammation protocol combines spirulina (mast cell stabilization via cAMP) + quercetin (IgE signaling and NF-κB suppression) + isoquercetin (superior quercetin bioavailability) + bromelain (absorption enhancement + independent anti-inflammatory) + MSM (cytokine suppression and antioxidant support) + DHA (resolution-phase anti-inflammatory). Each ingredient addresses the inflammatory cascade at a different point, and each has independent research support. Together they represent a multi-target approach that is more comprehensive than any pharmaceutical single-target intervention. Read the full research in the spirulina article, quercetin article, MSM article, and DHA article. For broader equine health context, see the Complete Guide to Horse Hydration.

  • OptiMSM: Why Manufacturing Process Matters for MSM Quality

    OptiMSM: Why Manufacturing Process Matters for MSM Quality

    Not all MSM is the same. The method by which methylsulfonylmethane is produced has a profound impact on its purity, contaminant profile, bioavailability, and stability. OptiMSM® (manufactured by Bergstrom Nutrition) is the only MSM produced in the United States using a multi-stage distillation process — a fundamentally different and superior manufacturing approach compared to the crystallization method used by most other MSM suppliers.

    Distillation vs. Crystallization: What It Means for Quality

    Most MSM on the market is produced via crystallization — a process that can trap impurities, residual solvents, and heavy metals within the crystal matrix. Crystallized MSM may appear pure by simple assay but can contain occluded contaminants that are not detected by basic testing.

    OptiMSM uses a multi-stage distillation process, which:

    • Removes impurities through repeated volatilization — only compounds that vaporize at the same temperature as MSM carry through, and these are then condensed to exceptionally high purity
    • Eliminates heavy metals, residual solvents, and biological contaminants that cannot volatilize
    • Produces a consistently 99.9%+ pure product with no crystallization-trapped impurities
    • Has been manufactured in the USA since 1989 under pharmaceutical-grade quality controls

    Research Conducted with OptiMSM

    Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement

    Butawan M, Benjamin RL, Bloomer RJ. Nutrients. 2017;9(3):290.
    DOI: 10.3390/nu9030290 | PMID: 28300758 | Free PMC Article

    This review — co-authored by Bergstrom Nutrition’s research director Rodney Benjamin — provides the most comprehensive overview of MSM research available. The body of clinical evidence supporting MSM’s safety and efficacy has been built almost exclusively using OptiMSM, which means:

    • The documented safety data (GRAS status, FDA DSHEA compliance, toxicology studies) was established using distilled OptiMSM
    • The clinical trials demonstrating anti-inflammatory effects used OptiMSM as the test article
    • Researchers cannot assume that crystallized MSM from other sources has the same purity, stability, or bioavailability profile as the product used in published studies

    Effects of MSM on Exercise-Induced Oxidative Stress (Clinical Trial with OptiMSM)

    Withee ED, Tippens KM, Dehen R, et al. Journal of the International Society of Sports Nutrition. 2017;14:24.
    DOI: 10.1186/s12970-017-0181-z | PMID: 28736511 | Free PMC Article

    This randomized, double-blind, placebo-controlled trial specifically used OptiMSM as the supplemental form, demonstrating significant reductions in post-exercise oxidative stress and muscle damage. The use of distilled OptiMSM ensured that the measured effects were attributable to pure MSM rather than confounded by impurities present in lower-quality crystallized products.

    Stability Advantage

    Distilled MSM is also more stable over time. Crystallized MSM can absorb moisture, clump, and begin to degrade, reducing potency and shelf life. The distillation process produces a hygroscopically stable compound that maintains potency throughout its labeled shelf life — an important consideration for equine supplements that may be used over extended periods.

    Why This Matters for Improve Equine Benchmark

    Benchmark uses OptiMSM exclusively. This means your horse receives the same purity and quality that has been validated in peer-reviewed clinical research — not a generic crystallized product of unknown provenance. When evaluating any MSM supplement, asking whether it contains OptiMSM (distilled) versus generic crystallized MSM is one of the most important quality questions you can ask.

    Note: OptiMSM® is a registered trademark of Bergstrom Nutrition. Always consult a veterinarian regarding your horse’s supplementation needs.

    Frequently Asked Questions: OptiMSM and MSM Quality for Horses

    What is OptiMSM and why does it matter for horses?

    Short answer: OptiMSM is the only MSM produced in the United States via multi-stage distillation, resulting in 99.9%+ purity without the crystallization-trapped impurities found in most generic MSM — and it is the form used in virtually all published MSM clinical research. This distinction matters because the safety data, GRAS designation, and clinical trial results that support MSM supplementation were generated using OptiMSM specifically. Generic crystallized MSM may test as “pure” on basic assays but can contain occluded heavy metals and residual solvents not detectable by standard testing. For horses under therapeutic supplementation, receiving the same form studied in peer-reviewed trials is a meaningful quality assurance.

    Is there a quality difference between MSM supplements for horses?

    Short answer: Yes — the manufacturing method is the single most important quality indicator for MSM. Distillation-process MSM (OptiMSM) is demonstrably purer and more stable than crystallization-process MSM, and the entire body of clinical evidence supporting MSM’s efficacy was built with distilled OptiMSM. Most MSM sold in equine supplements is crystallized and sourced from generic overseas manufacturers without the same quality controls. Asking whether a supplement contains OptiMSM by name is the most direct way to assess quality. The price difference between OptiMSM-based supplements and generic MSM products reflects a real difference in purity and traceability — not marketing.

    How does OptiMSM compare to standard MSM for equine joint support?

    Short answer: All of the clinical evidence supporting MSM’s joint health benefits — reduced pain scores, improved physical function, cartilage-protective effects — was generated using OptiMSM. You cannot assume generic crystallized MSM delivers the same outcomes. The sulfur in MSM supports cartilage matrix integrity through glycosaminoglycan synthesis, while its anti-inflammatory properties reduce the cytokine-driven degradation of collagen. These effects were demonstrated in studies using OptiMSM as the test article. When evaluating an equine joint supplement, confirming that it contains OptiMSM rather than generic MSM is one of the most important label-reading distinctions you can make. See the detailed research in the MSM inflammation article.

    Is OptiMSM stable in horse supplements over time?

    Short answer: Yes — distillation-process MSM is hygroscopically stable and maintains potency throughout its labeled shelf life, unlike crystallized MSM which can absorb moisture, clump, and begin to degrade. For equine supplements used over extended periods — particularly in the barn environment where temperature and humidity fluctuate — product stability is a practical concern. A supplement that has degraded to 60% potency by the time it’s used is not delivering what the label claims. OptiMSM’s stability advantage is particularly relevant for horses on ongoing therapeutic protocols where consistent dosing matters for maintaining the anti-inflammatory and antioxidant effects demonstrated in research.

    Where does Improve Equine source its MSM?

    Short answer: Benchmark uses OptiMSM exclusively — the distilled, US-manufactured form validated in peer-reviewed clinical research, not a generic crystallized product. The commitment to using OptiMSM rather than a cheaper generic MSM is one of the clearest expressions of the Improve Equine philosophy: ingredient sourcing decisions should be traceable to the research. If a study showing MSM’s anti-inflammatory benefits used OptiMSM, then giving your horse a different, less-pure form of MSM is not delivering what the study demonstrated. Read more about the Benchmark product and the science behind it on the Benchmark page, and explore the full ingredient library at the Improve Equine Library. For overall horse health context, see the Complete Guide to Horse Hydration.

  • MSM and Inflammation in Horses: Joints, Airways, and Skin

    MSM and Inflammation in Horses: Joints, Airways, and Skin

    Methylsulfonylmethane (MSM) is an organosulfur compound that serves as a bioavailable source of dietary sulfur — an essential element in collagen synthesis, glutathione production, and inflammatory pathway regulation. MSM has been extensively studied for its anti-inflammatory, antioxidant, and immunomodulatory properties, with applications particularly relevant to equine joint health, respiratory inflammation (heaves/equine asthma), and hypersensitivity skin conditions.

    Key Research

    Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement (Review)

    Butawan M, Benjamin RL, Bloomer RJ. Nutrients. 2017 Mar 16;9(3):290.
    DOI: 10.3390/nu9030290 | PMID: 28300758 | Free PMC Article

    This comprehensive review (University of Memphis and Bergstrom Nutrition, maker of OptiMSM®) synthesizes the available human and animal research on MSM, finding consistent evidence across multiple health outcomes:

    • Anti-inflammatory: MSM significantly reduces inflammatory markers including IL-1β, IL-6, TNF-α, and NF-κB — the same cytokines elevated in equine inflammatory conditions
    • Joint health: Multiple clinical trials demonstrate MSM reduces joint pain and improves physical function in osteoarthritis patients; animal models confirm cartilage-protective effects
    • Antioxidant capacity: MSM increases glutathione and other antioxidant enzymes, reducing oxidative stress in musculoskeletal and mucosal tissues
    • Hypersensitivity: MSM is listed in MeSH as indicated for hypersensitivity/allergy treatment, with studies demonstrating anti-allergic effects including mast cell inhibition
    • Safety: MSM is GRAS (Generally Recognized As Safe) and well-tolerated at doses up to 4g/day in humans; equine dosing is scaled accordingly

    Systematic Review of MSM in Osteoarthritis Treatment

    Brien S, Prescott P, Bashir N, Lewith H, Lewith G. Osteoarthritis and Cartilage. 2008 Nov;16(11):1277–88.
    DOI: 10.1016/j.joca.2008.03.002 | PMID: 18417375

    This systematic review evaluated the evidence base for MSM in osteoarthritis and found that MSM consistently produced significant reductions in pain scores and improvements in physical function in controlled trials. The sulfur component of MSM is believed to support cartilage matrix integrity by providing substrate for glycosaminoglycan synthesis and reducing the oxidative degradation of collagen.

    MSM for Exercise-Induced Oxidative Stress and Muscle Damage

    Withee ED, Tippens KM, Dehen R, et al. Journal of the International Society of Sports Nutrition. 2017;14:24.
    DOI: 10.1186/s12970-017-0181-z | PMID: 28736511 | Free PMC Article

    This randomized, double-blind, placebo-controlled trial found that MSM supplementation significantly reduced exercise-induced oxidative stress, muscle damage markers, and pain. These findings are directly relevant to working and competition horses experiencing the physical demands that precipitate musculoskeletal inflammation.

    Equine-Specific Considerations

    Horses with heaves (equine inflammatory airway disease / IAD) demonstrate elevated airway inflammation driven by the same cytokine pathways that MSM has been shown to downregulate. The skin sulfur content is particularly relevant to horses with chronic pruritic skin conditions, where sulfur-dependent barrier repair and mast cell stabilization are both implicated. MSM’s broad anti-inflammatory profile addresses joint, airway, and dermal inflammatory pathways simultaneously — making it well-suited to horses with complex, multi-system hypersensitivity presentations.

    Note: These studies provide evidence for MSM’s anti-inflammatory applications. Always consult a veterinarian regarding your horse’s specific health needs.

    Frequently Asked Questions: MSM for Horses

    What does MSM do for horses?

    Short answer: MSM reduces inflammation across joints, airways, and skin by suppressing key inflammatory cytokines (IL-1β, IL-6, TNF-α, NF-κB), supports cartilage integrity through dietary sulfur, and increases antioxidant capacity — making it one of the most versatile anti-inflammatory supplements in equine use. MSM’s broad mechanism of action makes it relevant to horses with joint problems, heaves or inflammatory airway disease, hypersensitivity skin conditions, and exercise-induced muscle damage. Its GRAS safety designation and well-established tolerance profile make it suitable for long-term daily supplementation in most horses.

    Is MSM good for horse joints?

    Short answer: Yes — MSM is one of the most research-supported natural joint supplements, with multiple clinical trials showing significant reductions in pain scores and improved physical function in osteoarthritis, plus animal model evidence for cartilage-protective effects. The sulfur in MSM provides raw material for glycosaminoglycan synthesis — the building blocks of healthy cartilage — while simultaneously reducing the oxidative processes that degrade collagen. For working and competition horses under regular physical stress, MSM addresses both the structural integrity of cartilage and the inflammatory responses triggered by exercise. The quality of MSM matters significantly; see the OptiMSM manufacturing quality article for why.

    Can MSM help horses with heaves or airway inflammation?

    Short answer: Yes — MSM’s cytokine suppression targets the same inflammatory pathways (IL-6, TNF-α, NF-κB) that are elevated in equine heaves, RAO, and inflammatory airway disease. Heaves and equine asthma involve chronic airway inflammation driven by mast cell activity and cytokine cascades. MSM downregulates multiple points in these cascades simultaneously. For horses with both airway and skin hypersensitivity, MSM’s multi-system anti-inflammatory profile — covering joint, airway, and dermal targets in one compound — makes it an efficient addition to an immune support protocol alongside quercetin, isoquercetin, and spirulina.

    Does MSM help with horse muscle recovery after exercise?

    Short answer: Yes — controlled trials show MSM significantly reduces exercise-induced oxidative stress, muscle damage markers, and post-exercise pain, making it directly relevant to working and competition horses. The physical demands placed on performance horses — particularly jumping, racing, and endurance disciplines — generate significant oxidative stress and inflammatory load in muscle tissue. MSM’s ability to increase glutathione and reduce oxidative damage supports faster recovery, reduced soreness, and lower cumulative inflammatory burden over a competition season.

    Does the type of MSM matter — is OptiMSM better than regular MSM?

    Short answer: Yes — manufacturing process has a direct impact on MSM purity, contaminant profile, and efficacy. OptiMSM, produced via multi-stage distillation, is the only MSM manufactured in the United States and represents the highest purity standard available. Most MSM on the market is produced via crystallization, a process that can leave chemical residues in the finished product. Distillation-process MSM removes these residuals entirely. For horses supplemented therapeutically — where consistent blood levels of a clean compound matter — the manufacturing process is not a marketing distinction but a genuine quality difference. See the full breakdown in the OptiMSM manufacturing quality article. For broader horse health context, visit the Complete Guide to Horse Hydration and the Improve Equine Library.

  • Isoquercetin: Greater Bioavailability Than Quercetin

    Isoquercetin: Greater Bioavailability Than Quercetin

    Quercetin is a powerful anti-allergic and anti-inflammatory flavonoid, but it faces a significant limitation: poor oral bioavailability. In its aglycone (free) form, quercetin is only approximately 4% bioavailable after oral administration. Isoquercetin (quercetin-3-O-glucoside, also called isoquercitrin) is a naturally occurring glycoside form of quercetin that is absorbed more rapidly and at significantly higher levels — making it the preferred form for systemic anti-inflammatory and anti-allergic applications.

    Key Research

    Oral Bioavailability of Quercetin from Different Quercetin Glycosides in Dogs

    Reinboth M, Wolffram S, Abraham G, Ungemach FR, Cermak R. British Journal of Nutrition. 2010 Jul;104(2):198–203.
    DOI: 10.1017/S000711451000053X | PMID: 20230651

    This University of Leipzig study conducted in dogs — a relevant mammalian model — directly compared the bioavailability of quercetin aglycone versus isoquercetin (isoquercitrin) and rutin at equivalent molar doses. Key findings:

    • The absolute bioavailability of quercetin aglycone was only ~4% — the vast majority is not absorbed systemically
    • Isoquercetin (isoquercitrin) was 1.5× more bioavailable than quercetin aglycone, with faster absorption peaking earlier
    • Both quercetin and isoquercetin were primarily absorbed in the small intestine, with peak plasma concentrations of 0.89 µmol/L achieved with isoquercetin
    • The superior bioavailability of isoquercetin relates to its glucoside form: the glucose moiety allows recognition by sodium-dependent glucose transporters (SGLT1) in the small intestine wall, enabling direct uptake rather than requiring colonic microbial hydrolysis

    Enzymatically Modified Isoquercitrin Is Absorbed More Easily Than Other Quercetin Glycosides

    Makino T, Shimizu R, Kanemaru M, et al. Biological and Pharmaceutical Bulletin. 2009 Dec;32(12):2034–40.
    DOI: 10.1248/bpb.32.2034 | PMID: 19952424

    This study demonstrated that glucoside-conjugated forms of quercetin (including isoquercetin) are absorbed significantly more efficiently in the small intestine compared to the aglycone or rutin forms, with higher peak plasma concentrations and faster time to maximum concentration (Tmax). The study attributed this to direct transporter-mediated uptake rather than passive diffusion.

    Why Bioavailability Matters

    The biological activity of quercetin depends entirely on reaching systemic circulation. A compound that remains largely in the gut cannot stabilize mast cells in the airways, skin, or joints. Isoquercetin’s superior absorption means a given dose delivers meaningfully more active compound to target tissues — including the respiratory mucosa, dermal mast cells, and synovial tissues relevant to equine inflammatory conditions.

    Relevance to Equine Supplementation

    For horses supplemented to support histamine response, airway health, or skin conditions, the form of quercetin used in a supplement has a direct impact on efficacy. Isoquercetin’s 1.5× greater bioavailability compared to quercetin aglycone means more active compound reaches the tissues where mast cell stabilization is needed most.

    Note: These studies provide mechanistic and comparative evidence for isoquercetin’s superior absorption. Always consult a veterinarian regarding your horse’s specific health needs.

    Frequently Asked Questions: Isoquercetin for Horses

    What is isoquercetin and why is it better than regular quercetin for horses?

    Short answer: Isoquercetin is the glycoside form of quercetin — it is absorbed 1.5× more efficiently because the attached glucose molecule allows it to use intestinal glucose transporters rather than relying on slower passive diffusion. Standard quercetin aglycone has only about 4% oral bioavailability, meaning 96% of what you give your horse passes through without entering circulation. Isoquercetin peaks faster and reaches higher plasma concentrations, which matters when the therapeutic goal is reaching mast cells in the skin, airways, and joints. For horses with allergic conditions where quercetin’s anti-inflammatory benefits are needed systemically, the form you supplement with has a direct impact on whether it works.

    Is isoquercetin safe for horses with sweet itch or insect bite hypersensitivity?

    Short answer: Yes — isoquercetin’s superior bioavailability makes it more effective than standard quercetin for horses with insect bite hypersensitivity, sweet itch, and other IgE-mediated allergic skin conditions. The mast cells in equine skin that drive insect bite hypersensitivity responses are exactly the target of quercetin-family compounds. Because isoquercetin reaches systemic circulation at higher concentrations than standard quercetin, it delivers more of the active mast cell-stabilizing compound to dermal tissue. Combined with spirulina and bromelain, it forms the core of a science-based equine allergy support protocol.

    How does bromelain interact with isoquercetin in horses?

    Short answer: Bromelain further enhances quercetin and isoquercetin absorption by breaking down the protein matrix in the gut that can interfere with flavonoid uptake, producing synergistic bioavailability effects beyond what either compound achieves alone. Bromelain is a proteolytic enzyme that has been specifically studied for its ability to enhance quercetin bioavailability. The combination of isoquercetin (already high-bioavailability quercetin) plus bromelain represents a compounding absorption advantage. See the bromelain absorption research article for the mechanism details.

    Can isoquercetin help horses with heaves or equine asthma?

    Short answer: Yes — isoquercetin’s superior systemic bioavailability means more quercetin reaches the respiratory mucosa where mast cell stabilization is needed for horses with heaves, RAO, and inflammatory airway disease. Equine asthma and heaves involve chronic mast cell-driven inflammation in the airways. The quercetin delivered via isoquercetin suppresses IgE receptor signaling and NF-κB activation — both key drivers of airway inflammatory responses. Because respiratory tissue is a systemic target (not a gut target), the higher plasma concentrations achieved with isoquercetin are particularly meaningful for horses with airway conditions.

    What is the full quercetin-family stack for equine allergy support?

    Short answer: The most research-supported quercetin-family approach for horses combines quercetin + isoquercetin + bromelain — each addressing a different aspect of absorption and inflammatory pathway suppression for comprehensive mast cell support. Quercetin provides broad-spectrum mast cell stabilization. Isoquercetin provides higher systemic bioavailability of quercetin. Bromelain enhances absorption of both and adds its own anti-inflammatory effects. Together with spirulina (which works via a separate cAMP-dependent mechanism), this stack covers the allergic cascade from multiple directions. Read the full research in the quercetin article, spirulina article, and bromelain article. For overall context on equine health and hydration, see the Complete Guide to Horse Hydration.

  • Quercetin and Mast Cell Histamine Response

    Quercetin and Mast Cell Histamine Response

    Quercetin is a naturally occurring flavonoid found in many plants. It is one of the most extensively studied natural compounds for its ability to inhibit mast cell degranulation — the process that releases histamine and other pro-inflammatory cytokines responsible for allergic symptoms. Research consistently shows quercetin outperforms pharmaceutical mast cell stabilizers in human cell studies.

    Key Research

    Quercetin Is More Effective Than Cromolyn in Blocking Human Mast Cell Cytokine Release

    Weng Z, Zhang B, Asadi S, et al. PLOS ONE. 2012;7(3):e33805.
    DOI: 10.1371/journal.pone.0033805 | PMID: 22470478 | Free PMC Article

    This landmark Tufts University School of Medicine study compared quercetin directly against cromolyn (the only pharmaceutical compound marketed as a mast cell stabilizer) using cultured human mast cells and human clinical trials. Key findings:

    • Both quercetin and cromolyn effectively inhibited histamine and prostaglandin D2 (PGD2) secretion from human mast cells
    • Quercetin was significantly more effective than cromolyn at inhibiting IL-8 and TNF release — inflammatory cytokines that sustain allergic reactions
    • Quercetin reduced IL-6 from mast cells in a dose-dependent manner
    • Quercetin inhibited cytosolic calcium increases and NF-κB activation — two core mechanisms driving mast cell inflammatory signaling
    • Critically: quercetin works prophylactically (before exposure), while cromolyn must be given simultaneously with the trigger or rapidly loses effectiveness
    • In two open-label human clinical trials, quercetin significantly reduced contact dermatitis and photosensitivity

    Quercetin and Its Anti-Allergic Immune Response (Review)

    Mlcek J, Jurikova T, Skrovankova S, Sochor J. Molecules. 2016 May 12;21(5):623.
    DOI: 10.3390/molecules21050623 | PMID: 27187333 | Free PMC Article

    This comprehensive review examines quercetin’s anti-allergic mechanisms across multiple cell types, finding that quercetin suppresses IgE receptor-mediated mast cell activation, inhibits the secretion of multiple histamine and eicosanoid mediators, and downregulates Th2-type immune responses that underlie chronic allergic conditions.

    Mechanism of Action

    Quercetin stabilizes mast cells by multiple complementary pathways: it blocks the IgE-FcεRI receptor complex signaling cascade, inhibits intracellular calcium release (which triggers degranulation), and suppresses NF-κB activation that drives cytokine gene expression. This multi-target approach makes quercetin particularly effective for broad-spectrum anti-allergic support.

    Relevance to Equine Health

    The mast cell biology studied in these human and rat models is directly analogous to the mast cell-mediated hypersensitivity seen in horses with insect bite hypersensitivity, heaves (equine asthma), and skin allergies. Quercetin’s prophylactic effectiveness — working best when given consistently before allergen exposure — aligns well with daily supplementation protocols for horses in high-allergen environments.

    Note: These studies provide mechanistic and clinical evidence for quercetin’s anti-allergic activity. Always consult a veterinarian regarding your horse’s specific health needs.

    Frequently Asked Questions: Quercetin for Horses

    What does quercetin do for horses?

    Short answer: Quercetin stabilizes mast cells, reduces histamine release, and suppresses multiple inflammatory pathways — making it one of the most research-supported natural anti-allergic compounds for horses with hypersensitivity conditions. In direct comparison studies, quercetin outperformed cromolyn — the only pharmaceutical mast cell stabilizer — at blocking IL-8 and TNF release. Unlike most anti-allergic interventions, quercetin works prophylactically: it is most effective when given consistently before allergen exposure rather than reactively after symptoms appear. This makes it particularly well-suited to horses in year-round or seasonal allergy management protocols.

    Is quercetin better than antihistamines for horses?

    Short answer: Quercetin and antihistamines work differently — antihistamines block histamine after it’s released, while quercetin prevents the mast cells from releasing histamine in the first place. For horses with chronic allergic conditions like insect bite hypersensitivity, sweet itch, or equine asthma, preventing histamine release upstream is often more effective than blocking it downstream. Quercetin’s multi-target mechanism — blocking IgE signaling, intracellular calcium release, and NF-κB activation simultaneously — means it addresses the allergic cascade at multiple points rather than just one. For enhanced absorption, quercetin is most effective when paired with isoquercetin. See the isoquercetin bioavailability article for details.

    How long does quercetin take to work in horses?

    Short answer: Quercetin is a prophylactic — it builds effectiveness over consistent daily use and works best when given before allergen exposure, not after. Most horses show measurable improvement in 4–6 weeks of continuous supplementation. The research is clear that quercetin loses effectiveness rapidly when given simultaneously with an allergic trigger, but is highly effective when pre-loaded consistently. For horses with seasonal allergies, starting supplementation 4–6 weeks before peak season produces the best outcomes. For horses with year-round conditions like heaves, daily ongoing supplementation is the appropriate protocol.

    What is the difference between quercetin and isoquercetin for horses?

    Short answer: Isoquercetin is the glycoside form of quercetin with significantly higher bioavailability — the body absorbs it faster and at greater quantities, meaning more of the active compound actually reaches the mast cells where it needs to work. Standard quercetin aglycone has approximately 4% oral bioavailability. Isoquercetin, because it is attached to a glucose molecule, is absorbed via intestinal glucose transporters at a much higher rate. For horses where therapeutic effect matters, isoquercetin delivers more consistent blood levels of quercetin than the standard form. See the full isoquercetin bioavailability article for the research.

    Is quercetin safe for horses with sweet itch or insect bite hypersensitivity?

    Short answer: Yes — quercetin is one of the most scientifically supported natural interventions for horses with insect bite hypersensitivity (IBH) and sweet itch, directly targeting the mast cell and Th2-immune mechanisms that drive these conditions. Insect bite hypersensitivity is the most common allergic skin condition in horses globally. The Culicoides midge allergens that trigger IBH activate IgE-mediated mast cell degranulation — exactly the pathway quercetin blocks at multiple points. For the most comprehensive approach, combining quercetin with isoquercetin, spirulina, and bromelain addresses the allergic cascade from multiple angles. Read more in the spirulina mast cell article and the bromelain absorption article. For overall horse health context, see the Complete Guide to Horse Hydration.

  • Spirulina and Mast Cell Histamine Response

    Spirulina (Arthrospira platensis) is a blue-green microalgae with well-documented anti-inflammatory properties. Research demonstrates that spirulina directly inhibits mast cell degranulation — the process by which mast cells release histamine and other inflammatory mediators that drive allergic reactions.

    Key Research

    Inhibitory Effect on Mast Cell-Mediated Immediate-Type Allergic Reactions

    Kim HM, Lee EH, Cho HH, Moon YH. Biochemical Pharmacology. 1998 Apr 1;55(7):1071–6.
    DOI: 10.1016/s0006-2952(97)00678-3 | PMID: 9605430

    This foundational study from Wonkwang University demonstrated that spirulina dose-dependently inhibits systemic allergic reactions in rats. Key findings included:

    • Spirulina completely blocked compound 48/80-induced systemic allergic reactions at doses of 100–1000 mcg/g body weight
    • Serum histamine levels were reduced in a dose-dependent manner
    • Histamine release from peritoneal mast cells was inhibited by up to 100% in vitro
    • Cyclic AMP levels in mast cells increased ~70-fold within 10 seconds of spirulina exposure, explaining the stabilizing mechanism
    • TNF-alpha production triggered by IgE was also significantly suppressed

    The researchers concluded that spirulina inhibits mast cell-mediated immediate-type allergic reactions through a cAMP-dependent mechanism that stabilizes the mast cell membrane and prevents degranulation.

    Effects of Spirulina on Allergic Rhinitis

    Cingi C, Conk-Dalay M, Cakli H, Bal C. European Archives of Oto-Rhino-Laryngology. 2008 Oct;265(10):1219–23.
    DOI: 10.1007/s00405-008-0642-8 | PMID: 18343939

    This clinical trial evaluated spirulina in patients with allergic rhinitis and found significant improvements in nasal discharge, sneezing, nasal congestion, and itching compared to placebo. Spirulina significantly reduced interleukin-4 (IL-4) levels — a key cytokine driving IgE-mediated allergic responses — indicating a modulation of the underlying Th2-dominant immune response that underlies hypersensitivity conditions.

    Relevance to Equine Health

    Horses with conditions such as Equine Recurrent Uveitis (ERU), insect bite hypersensitivity (sweet itch), summer seasonal recurrent dermatitis, and respiratory allergies (heaves/EGUS) exhibit elevated mast cell activity and histamine release patterns comparable to those studied in these models. Spirulina’s demonstrated ability to stabilize mast cells and reduce histamine release makes it a scientifically rational ingredient for supporting horses predisposed to these hypersensitivity responses.

    Note: These studies provide mechanistic and clinical evidence for spirulina’s anti-allergic activity. Always consult a veterinarian regarding your horse’s specific health needs.

    Frequently Asked Questions: Spirulina for Horses

    What does spirulina do for horses with allergies?

    Short answer: Spirulina stabilizes mast cells and reduces histamine release, directly addressing the biological mechanism behind most equine allergic reactions. Horses with insect bite hypersensitivity (sweet itch), summer seasonal recurrent dermatitis, heaves, and Equine Recurrent Uveitis all involve elevated mast cell activity. Spirulina works by increasing cyclic AMP levels in mast cells — a mechanism that prevents them from degranulating and dumping histamine. Research shows spirulina can inhibit histamine release by up to 100% in vitro, making it one of the most potent natural mast cell stabilizers available.

    How long does spirulina take to work in horses?

    Short answer: Spirulina works best as a consistent daily supplement — most horses show meaningful improvement in allergic symptoms within 4–8 weeks of continuous use. Like quercetin, spirulina’s anti-allergic benefit is prophylactic: it works best when given before allergen exposure, not as a reactive treatment after symptoms appear. Horses in high-allergen environments (insect-heavy summers, dusty hay) benefit most from year-round daily supplementation that keeps mast cell activity suppressed consistently.

    Is spirulina safe for horses with Cushing’s disease or insulin resistance?

    Short answer: Spirulina is generally considered safe for metabolic horses — it contains no sugar, no electrolytes, and no high-glycemic ingredients — but always confirm with your veterinarian for horses under active metabolic management. Metabolic horses are often the ones who most need immune support, since Cushing’s disease (PPID) dysregulates immune function and increases susceptibility to skin conditions and respiratory inflammation. Spirulina’s anti-inflammatory profile is particularly relevant for these horses. As with any supplement for a horse with a metabolic condition, consult your vet before introducing it.

    Can spirulina be combined with quercetin for horses?

    Short answer: Yes — spirulina and quercetin work through complementary mechanisms and are commonly combined in equine immune support protocols. Spirulina primarily stabilizes mast cells via a cAMP-dependent membrane mechanism, while quercetin blocks multiple downstream inflammatory pathways including IgE signaling and NF-κB activation. Together they address the allergic response from different angles. Many horses with significant hypersensitivity conditions benefit from a multi-ingredient approach. See the quercetin research article and the isoquercetin bioavailability article for details on how quercetin-family compounds work.

    Does spirulina help with equine heaves or respiratory inflammation?

    Short answer: Yes — spirulina’s ability to reduce IL-4 and mast cell-driven inflammation makes it a scientifically rational support for horses with heaves (equine asthma) and recurrent airway obstruction. The clinical research on allergic rhinitis shows spirulina significantly reduces interleukin-4, a cytokine that drives the Th2-dominant immune response underlying hypersensitivity conditions including respiratory allergies. Horses with heaves, RAO, or inflammatory airway disease have elevated mast cell activity in the airways — the same biological target spirulina addresses. For more context on the broader immune support picture, see the Complete Guide to Horse Hydration and the full Improve Equine Library. Spirulina is one of eight active ingredients in Benchmark — our science-forward equine supplement built on this research.